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Effect of in vivo contact between blood and dialysis membranes on
protein catabolism in humans. To investigate whether the contact
between blood and dialysis membranes might induce muscle protein
degradation, the exchange of free amino acids across leg tissues was
measured by catheterization technique in three groups of healthy
subjects before and after a 150 minute sham-hemodialysis procedure
(SHDP), that is, in vivo passage of blood (100 mI/mm) through a
dialyzer but with no circulating dialysate. Dialyzers with either regen-
erated cellulose membrane (group CU, N = 10 and group CU-IND, N
= 6) or polyacrylonitrile membrane (group AN, N = 8) were used In
group CU-IND indomethacin was administered before (100 mg) and at
the end (50 mg) of SHDP. Leg blood flow was measured by venous
occlusion plethysmography. In group CU net leg release of tyrosine and
phenylalanine increased from 3.4 0.8 and 3.6 0.8 nmol/min/100 g
tissue, respectively, before SHDP to 7.8 1.8 and 8.3 1.8nmol/min/
100 g tissue, respectively, at 345 minutes after the start of SHDP (P <
0.01). The total release of all measured amino acids increased from 148
31 to 309 50 nmol/min/lOO g tissue (P < 0.01). The results indicate
that interaction between blood and regenerated cellulose membranes
leads to accelerated net protein breakdown. In group CU-IND no
change in leg amino acid release was observed following SHDP,
suggesting that the increased net protein catabolism is mediated by
prostaglandins. Sham hemodialysis using AN membranes did not result
in increased amino acid efflux from leg tissues, implying that the protein
catabolic effect of blood-membrane contact depends on the biochemical
properties of dialyser.
Several reports have documented that malnutrition is fre-
quently present in patients undergoing maintenance hemodial-
ysis therapy (HD) [1—31. It is generally accepted that suboptimal
nutritional status is associated with increased morbidity and
may contribute to poor rehabilitation and quality of life [41. Low
nutritional intake, because of anorexia and vomiting, is a major
contributing factor to malnutrition in many hemodialysis pa-
tients. However, it has long been recognized that dietary
requirements of protein are higher in hemodialysis patients than
in normal subjects and non-dialyzed ureniics [5]. Healthy
subjects have a daily minimum protein requirement of 0.6 glkg
[6], and non-dialyzed uremic patients may be in nitrogen
balance on 0.6 glkglday of high quality protein [7] or less if the
diet is supplemented with essential amino acids [8] or their keto
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acids [9]. However, signs of malnutrition have been observed in
substantial numbers of apparently well rehabilitated hemodial-
ysis patients, who had a daily protein intake of about 1 g/kg
body wt/day [1].
There is now evidence that the hemodialysis procedure per se
is a strong catabolic stimulus [10]. This may be partly explained
by the loss of free amino acids into the dialysis fluid, a loss
reported to amount to 5 to 8 g per dialysis, about one third of
which consists of essential amino acids [11—14]. In addition 4 to
5 g of peptide bound amino acids are also lost per dialysis [11,
12]. Thus the total amount of amino acids lost is about 9 to 13
g per dialysis [11—13]. However, the loss of free and bound
amino acids is not sufficient to fully account for the increased
protein requirements in hemodialysis patients compared to
non-uremic individuals and non-dialyzed uremic patients. Con-
sequently, the possibility must be considered that additional
factors not related to the dialytic removal of amino acids are
involved.
Interaction between blood and artificial membranes in a
dialyzer induces biological effects such as stimulation of the
complement system, aggregation of granulocytes, transient
leucopenia and release of granulocytic enzymes, clotting and
thrombocyte activation [15]. It has been proposed that several
side-effects of hemodialysis might be attributed to the increased
release of cytokines from monocytes during dialysis, induced
by complement activation, endotoxins or acetate in the dialysis
fluid [16]. It has later been demonstrated that hemodialysis
leads to increased monokine production [17]. Also, it has been
shown that interleukin-1 (IL-I) levels are increased in hemodi-
alysis patients in the interdialytic period and that hemodialysis
leads to further increases in circulating IL-i levels [18]. Among
the established effects of monokines is the induction of protein
catabolism which seems to take place by way of a local release
of prostaglandin E2 in skeletal muscle, which in turn stimulates
lysosomal protein degradation. This mechanism has been pro-
posed for the increase in muscle protein breakdown observed in
trauma and sepsis [19, 20].
To investigate whether the blood-membrane interaction
might induce increased muscle protein catabolism, we studied
the exchange of free amino acids across the leg in 10 fasting
healthy subjects before and after a sham-hemodialysis proce-
dure, that is, in vivo passage of blood, but with no circulating
dialysate, through a dialyzer with regenerated cellulose mem-
brane. Our results indicate that interaction between blood and
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regenerated cellulose membranes leads to accelerated net pro-
tein breakdown. In six additional subjects to whom indometh-
acm was administered before and at the end of the sham
hemodialysis no increase in leg amino acid release was ob-
served, suggesting that the net increase in leg protein catabo-
lism is mediated by prostaglandins. Results of several studies
have shown that hemodialysis using a dialyzer of polyacryloni-
trile membranes leads to less pronounced complement activa-
tion and leukopenia as compared with regenerated cellulose
membranes [21]. Therefore sham hemodialysis was performed
using polyacrylonitrile membranes. In this series no increase in
leg amino acid release was observed, implying that the effect of
contact between blood and dialysis membrane also on protein
catabolism depends on membrane material.
Methods
Subjects
Three groups of healthy volunteers were studied. Ten sub-
jects (group CU), four females and six males, with a mean age
of 30 years (range 21 to 40 years) and a mean body weight
corresponding to 103 3% of ideal body weight (based upon
medium framed individuals, Metropolitan Life Insurance Ta-
bles, 1959) underwent sham hemodialysis using regenerated
cellulose membrane (Cuprophan). Six subjects (group CU-
IND), two females and four males, with a mean age of 28 years
(range 21 to 36 years) and with a body weight corresponding to
109 4% of ideal body weight, were studied with sham
hemodialysis using Cuprophan membrane, after administra-
tion of indomethacin. In eight subjects (group AN), seven males
and one female, with a mean age of 29 years (range 21 to 39
years) and with a body weight corresponding to 109 3% of
ideal body weight, sham hemodialysis was performed using a
membrane of polyacrylonitnle (AN69®). The nature, purpose
and potential risks of the study were carefully explained to all
subjects before they consented to participate in the study. The
study protocol was approved by the Ethics Committee of the
Karolinska Institute at Huddinge Hospital.
Protocol
All subjects were asked not to take any drugs or contracep-
tive pills for two weeks prior to the study. The subjects adhered
to their ordinary diet until the evening before the study when
they began an overnight fast. In all subjects polyethylene
catheters were inserted into a femoral artery and ipsilateral
femoral vein, for the amino acid determinations. One hour after
the insertion of these catheters blood samples were taken to
determine the basal plasma concentrations of amino acids.
Thereafter sham hemodialysis (vide infra) was started (0 mm).
In all subjects blood samples were taken after 150 and 345
minutes, and in five subjects of group CU also after 540
minutes. On each occasion four arterial and femoral venous
blood samples were taken for amino acid determination. At
each time point the arterial-femoral venous differences were
calculated as the mean difference between the four arterial and
venous plasma samples. Leg blood flow was measured by
venous occlusion plethysmography immediately after blood
sampling at each time point. Plasma flow (Q)was derived from
the subjects blood flow (Qb) and hematocrit (Htc) using the
formula Q = Qb X (100— Htc)/100. Leg amino acid balance
was calculated by multiplying the arterio-femoral venous con-
centration difference for individual amino acids multiplied by
leg plasma flow. The six subjects of group CU-IND were given
indomethacin by rectal administration at —60 minutes (100 mg)
and immediately after the sham hemodialysis procedure at 150
mm (50 mg).
Blood-membrane contact
Access for blood circulation through the dialyzer was ob-
tained by catheterization (at —60 mm) of the contralateral
femoral vein with a single lumen catheter and a cubital vein with
a dialysis needle. In groups CU and CU-IND sham hemodial-
ysis was performed using a plate dialyzer with regenerated
cellulose (Cuprophan®) membranes (Gambro Lundia 11.5 .t;1.0
m2) and in group AN Acrylonitrile-Sodium Methallyl Sulfonate
(AN69) membrane (Filtral 12; 1.15 m2). After rinsing the blood
and dialysate compartments of the dialyzer with one liter of
saline each, another liter of saline was passed through the blood
compartment and filtration of saline through the membrane was
achieved by using a negative transmembrane pressure of 440
mm Hg. During the sham hemodialysis procedure blood was
circulated through the dialyzer at a rate of 100 mI/mm for 150
minutes. The venous blood line was heated to 37°C, thereby
preventing the cooling of blood. To exclude the possibility of
ultrafiltration or diffusion of amino acids through the dialysis
membrane, no dialysate was circulated through the dialyzer and
the dialysate ports were clamped. Continuous monitoring of
blood flow, venous and arterial pressure, etc., was obtained
with a Gambro AK 10 monitor. Before blood circulation
through the dialyzer was started a single bolus dose of heparin
(100 IE/kg body wt) was administered intravenously.
Analytical methods
Blood samples for amino acid analysis were kept on ice.
Plasma proteins were precipitated with 4% sulphosalicylic acid.
Samples were then centrifuged at + 8°C and the supernatants
were kept frozen (—80°C) until analysis. Plasma concentrations
of individual amino acids were measured by ion exchange
chromatography using an automatic amino acid analyzer (LKB
4460). Asparagine and glutamate were not well separated by the
chromatography and are not reported.
Presentation of data
All data are presented as means SEM. Nonparametric
statistics were used. The Kruskal-Wallis followed by the Mann-
Whitney U test were used to test basal values in the three
groups. The Friedman two-way analysis of ranks and the
Wilcoxon matched-pairs signed-ranks test were applied to test
changes from basal values [22]. A two-tailed P value <0.05 was
considered statistically significant.
Results
Leg plasma flow
Data on plasma flow are given in Table I. The plasma flow did
not differ significantly between the three groups. Following
sham dialysis plasma flow increased significantly in groups CU
and CU-IND. At 345 minutes, plasma flow was on average 75%
higher in group CU (P < 0.02) and 48% higher in group CU-IND
(P < 0,05) compared with basal values. In the five subjects of
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Table 1. Leg plasma flow in the basal state and at 150 and 345 mm
after the start of sham hemodialysis
Group
Basal
mean SEM
150 mm
mean SEM
345 mm
mean SEM
CU 0.75 0.15 0.81 0.14 1.31 013b
CU-IND 0.54 0.09 0.73 0.06a 0.80 o.lOa
AN 0.74 0.17 0.50 0.04 0.70 0.10
Table 2. Arterial amino acid concentrations in the basal state and at
150 and 345 minutes after the start of sham hemodialysis
Basal 150 mm 345 mm
Group mean SEM mean SEM mean SEM
ASP CU 7±1 7±1 7±1
CU-IND 6±1 5±1 5±1
AN 5±0.4a 5±1 5±1
THR CU
CU-IND
AN
95±9
143 l1
128 14
92±6
133 9
130 14
88±6
120 8
124 11
SER CU
CU-IND
AN
95±7
147 12
116 13
96±8
145 9
122 11
97±7
135 12
117 10
GLN CU
CU-IND
AN
598 47
828 119
635 32
573 57
801 108
637 32
537 63
788 103
633 35
GLY CU
CU-IND
AN
156 12
251 26
235 2l
155 13
233 21
230 22
150 11
245 26
234 15
ALA CU
CU-IND
AN
167 13
235 14
222 16
158 13
234 16
226 17
150 12
219 15
206 15
VAL CU
CU-IND
AN
181 15
253 l9
218 13
195 15
253 21
221 15
204 16
257 19
223 11
ILE CU
CU-IND
CONTROL
45±5
74 7
55 5
48±5
70 6
58 5
50±5
71 6
60 5
LEU CU
CU-IND
AN
93 10
140 12
57±6
113 11
147 14
57±4
122 11
154 12
62±2
TYR CU
CU-IND
AN
41±4
63 3
54÷3a
41±3
53 4
52±3
42±3
54 3
50±3
PHE CU
CU-IND
AN
40±3
53 2
51±4
45±3
58 4
53±3
46±3
59 3
54±1
LYS CU
CU-1ND
AN
143 12
184 4
174 ioa
158 11
206 8
194 10
155 10
197 5
182 12
HIS CU
CU-IND
AN
64±5
79 3
84±5a
67±4
82 3
92±7
67±4
77 2
92±3
ARG CU
CU-IND
AN
65±5
93 14
77±5
66±5
92 9
80±4
65±6
89 7
82±5
AA CU
CU-IND
AN
1783 116
2516 144
2167 98
1808 121
2482 124
2226 79
1772 111
2438 148
2193 84
Data are expressed as ml/min/100 g tissue.
aP < 0.05 compared with basal
bP < 0.02 compared with basal
group CU in whom plasma flow was measured at 540 minutes,
a tendency to return toward basal levels was observed. There
was no significant change in plasma flow in the AN-group.
Plasma amino acid concentrations
The arterial concentrations of individual amino acids in
plasma are given in Table 2. In the basal state lower plasma
concentration levels of several amino acid were observed in the
CU group than in the CU and AN groups. The sum of all
measured amino acids was significantly lower in the CU group
than in the CU-IND and AN groups (P < 0.05). Individual
amino acid levels and total amino acid concentration did not
change from basal values in any of the groups during the 345 to
540 minute observation period.
Arterio-venous amino acid differences
In the basal state the arterio-venous amino acid differences
tended to be larger in the CU-IND group than in the CU group,
but the difference reached statistical significance only for phe-
nylalanine and histidine (Table 3). However, calculated for all
measured amino acids the difference was not significant (P =
0.11). The arterio-venous difference for histidine was larger in
the AN-group than in the CU-group. Following sham hemodi-
alysis the arterio-venous differences of all individual amino
acids tended to increase in CU-group. Calculated for all mea-
sured amino acids the arterio-venous concentration difference
was —198 20 jxmol/liter in the basal state and —247 27
jsmoLlliter at 345 minutes (P < 0.01). In group CU-IND,
arterio-venous concentration differences tended to be smaller at
345 minutes compared with basal values, but this change did not
reach statistical significance. The arterio-venous differences did
not change significantly in AN-group.
Leg amino acid exchange
Data on leg amino acid exchange in the three study groups are
given in Table 4. In group CU net release of leg amino acids
remained constant during the 150 minutes of the sham-HD
procedure, but increased markedly during the following hours.
Compared with basal release the total efilux of all measured
amino acids approximately doubled at 345 minutes (P < 0.01,
Fig. 1). Significant increases were also observed for threonine,
alanine, leucine, tyrosine, phenylalanine, lysine and histidine (P
< 0.01 to 0.05). In the five subjects of group CU who were
followed for 540 minutes after the start of sham hemodialysis
the total release of all measured amino acids reached its
maximum at 345 minutes (212 63 nmol/min/l00 g tissue, P <
0.05 vs. basal). Thereafter release tended to decrease, but the
efflux was still higher at 540 minutes (173 81 nmol/min/100 g
Data are expressed as smol/liter.
a P < 0.05 compared with group CU
tissue,) than before the start of sham hemodialysis (88 30
nmol/min/I0O g tissue), although the difference did not reach
statistical significance. No significant changes in the release of
any individual amino acid or the sum of all measured amino
acids were observed at 150 or 345 minutes in CU-IND and
AN-groups.
Discussion
The purpose of this study was to study the effect of in vivo
contact between blood and regenerated cellulose dialysis mem-
branes on protein metabolism by the measurement of the
exchange of free amino acids across the leg. The leg amino acid
exchange was measured in normal subjects before and aftes
sham hemodialysis, that is, in vivo passage of blood through a
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dialyzer for 150 minutes, but with no circulating dialysate. The
sham-HD procedure was designed to establish a continuous in
vivo contact between blood and dialysis membranes, resem-
bling that occurring during a clinical hemodialysis treatment,
and to avoid the loss of amino acids from the blood by dialysis.
Following sham-HD a significant increase in net release of
amino acids from the leg was observed in the CU group. At 345
minutes after the start of sham-HD the total release of all
measured amino acids was approximately doubled compared
with the basal state (Fig 1). Similar increases in efflux were
observed for most individual amino acids.
It should be emphasized that the precision of tissue balance
calculations is critically dependent on the accuracy of the
measurements of amino acid concentrations and blood flow. In
group CU the enhanced release of amino acids at 345 minutes
was associated with marked increases in leg blood flow. An
overestimation of leg blood flow could thus have led to an
erroneous conclusion of increased leg amino acid release.
However, several reasons render this possibility unlikely. First,
the values of resting blood flow observed in the present study
agree with previously reported measurements of blood flow
using occlusion plethysmography [23]. Second, the increase in
leg blood flow of approximately 75% (P < 0.01) is out of
proportion to the methodological error involved in the estima-
tion of leg blood flow by occlusion plethysmography. In our
study the coefficient of variation for the determinations of leg
blood flow, based on repeated measurements at each time point
ASP
Table
state and
3. Arterio-femoral venous amino acid differences in the basal
at 150 and 345 minutes after the start of sham hemodialysis
Basal 150 mm 345 mm
Group mean SEM mean 5EM mean SEM
ASP
Table 4. Leg exchange of amino acids in the basal state and at 150
and 345 mm after the start of sham hemodialysis
Basal 150 mm 345 mm
Group mean SEM mean SEM mean SEM
CU 0.4 1.0 0.7 1.0 1.0 0.0 CU 0.3 0.3 0.6 0.5 0.6 0.6
CU-IND 1.2 0.5 0.7 0.5 0.0 0.5 CU-IND 0.5 0.2 0.8 0.4 0.0 0.3
AN 0.7 0.1 0.7 0.3 0.3 0.4 AN 0.6 0.3 0.3 0.2 0.2 0.3
THR CU —13.0 2.0 —9.0 3.0 —15.0 2.0 THR CU —11.2 3.0 —7.7 2.5 —17.4 33a
CU-IND —19.0 2,0 —14.0 3.0 —15.0 4.0 CU-IND —10.5 2.2 —10.9 2.4 —11.1 3.5
AN —13.7 2.0 —12.5 2.4 —16.1 3.5 AN —9.1 1.7 —5.7 0.9 —10.1 2.2
SER CU 5.0 3.0 5.0 3.0 3.0 1.0 SER CU 3.5 1.9 3.2 1.6 4.2 1.5
CU-IND 3.0 2.0 —1.0 6.0 1.0 2.0 CU-IND 0.8 1.0 —2.1 4.5 l.4 1.7
AN 1.6 2.3 —31.1 35.0 0.9 2.4 AN 1.7 1.9 —15.2 18.0 0.4 1.7
GLN CU —75.0 12.0 —78.0 15.0 —86.0 11.0 GLN CU —52.0 13.0 —62.0 18.0 —117.0 19.0
CU-IND —115.0 27.0 —110.0 32.0 —98.0 25.0 CU-IND —69.0 25,0 —92.0 25.0 —74.0 21.0
AN —63.0 13.0 —82.0 18.0 —72.0 14.0 AN —41.3 11.8 —37.3 6.2 —45.1 8.3
GLY CU —15.0 3.0 —13.0 3.0 —18.0 2.0 GLY CU —12.3 4.6 —11.8 3.9 —21.1 3.6
CU-IND —25.0 4.0 —39.0 16.0 —24.0 5.0 CU-IND —13.8 3.6 —38.5 15.1 —17.6 3.2
AN —18.8 2.7 —18.5 5.0 —22.0 6.3 AN —11.6 1.9 —8.5 2.1 —12.9 3.2
ALA CU —56.0 4.0 —61.0 5.0 —63.0 7.0 ALA CU —42.3 9.1 —51.2 11.5 —76.4 12.0"
CU-IND —86.0 8.0 —72.0 12.0 —64.0 14.0 CU-IND —45.5 8.9 —52,2 9.2 —45.2 6.0
AN —55.5 13.0 —72.3 18.0 —57.0 17.0 AN —32.7 7.3 —32.6 6.2 —33.0 8.0
VAL CU —4.0 2.0 2.0 4.0 —8.0 2.0 VAL CU —3.0 1.6 —1.2 4.4 —10.1 4.3
CU-IND —8.0 3.0 —8.0 6.0 —5.0 4.0 CU-IND —4.6 1.4 —6.6 4.6 —3.2 3.2
AN —7.1 3.1 —1.8 2.0 —7.3 3.3 AN —3.7 2.5 —0.5 1.0 —4.4 2.1
ILE CU —3.0 2.0 —3.0 2.0 —4.0 1.0 ILE CU —2.3 0.6 —2.8 0.7 —5.1 1.4
CU-IND —4.0 1.0 —5.0 2.0 —4.0 1.0 CU-IND —2.1 0.7 —4.0 1.8 —3.0 1.1
AN —4.8 1.5 —2.6 0.7 —3.7 1.8 AN —2.5 0.9 —1.2 0.3 —2.3 1.2
LEU CU —5,0 2.0 —3.0 2.0 —9.0 2.0 LEU CU —4.0 0.9 —3.3 1.2 —12.0 3.3"
CU-IND —9.0 1.0 —9.0 5.0 —8.0 1.0 CU-IND —4.7 1.0 —7.1 3.5 —5.5 0.8
AN —9.6 3.2 —3.1 2.0 —6.4 3.3 AN —5.8 1.7 —1.2 0.7 —3.9 2.2
TYR CU —4.0 1.0 —4.0 2.0 —7.0 1.0 TYR CU —3.4 0.8 —4.3 1.3 —7.8 18b
CU-IND —7.0 0.5 —6.0 2.0 —5.0 1.0 CU-IND —3.5 0.6 —4.7 1.1 —3.8 0.5
AN —5.8 0.7 —4.9 1.0 —5.9 1.4 AN —4.3 1.0 —2.4 0.6 —4.0 1.1
PHE CU —5,0 1.0 —5.0 2.0 —7.0 1.0 PHE CU —3.6 0.8 —4.4 1.3 —8.3 1.8c
CU-IND —8.0 1,oa —6.0 2.0 —6.0 1.0 CU-IND —4.6 1.0 —4.9 1.5 —4.1 0.5
AN —5.4 1.3 —5.0 1.9 —6.4 1.8 AN —3.4 0.8 —2.2 0.7 —3.8 1.0
LYS CU —12.0 3.0 —11.0 3.0 —17.0 3.0 LYS CU —10.4 3.0 —10.1 3.5 —21.8 5.0
CU-IND —17.0 4.0 —15.0 8.0 —14.0 5.0 CU-IND —8.4 1.8 —12.0 5.9 —9.6 2.9
AN —11.3 4.3 —9.6 2,8 —16.3 3.6 AN —7.9 2.7 —4.1 0.9 —10.0 2.0
HIS CU —3.0 2.0 —3.0 2.0 —6.0 1.0 HIS CU —1.5 0.6 —3.6 1.7 —7.4 1.6c
CU-IND —8.0 1.oa —6.0 2,0 —7.0 2.0 CU-IND —4.5 0.9 —4.3 1.3 —4,9 1.5
AN —8.9 0,7a —4.5 1.1 —7.0 2.5 AN —6.3 1.4 —2.1 0.6 —4.4 1.7
ARG CU —7.0 3.0 —7.0 2.0 —11.0 2.0 ARG CU —6.3 2.6 —5.9 1.3 —10.3 2.8
CU-IND —8.0 5.0 —11.0 4.0 —14.0 1.0 CU-IND —5.3 2.9 —9.3 2.9 —10.6 2.4
AN —7.3 1.5 —8.1 3.1 —9.9 1.7 AN —5.7 1.4 —3,5 1.2 —6.3 1.2
AA CU —198.0 20.0 —174.0 11.0 —247.0 270b AA CU —148.0 31.0 —152.0 41.0 —309.0 50.0
CU-IND —307.0 37.0 —297.0 71.0 —258.0 56.0 CU-IND —171.0 45.0 —215.0 55.0 —188.0 37.0
AN —209.0 40,0 —255.0 41.0 —228.0 53.0 AN —133.0 31.0 —116.0 6.7 —140.0 28.0
Data are expressed as mol/1iter.
a P < 0.05 compared with CU
b P < 0.01 compared wtih basal
Data are expressed as nmollmin/100 g tissue.
a p < 0.05 compared with basalbp < 0.02 compared with basal
C p < 0.0! compared with basal
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Basa1150345 Basal 150345 Basal 150345 mm
1I1
Basal 150 345 Basal 150345 Basal 150345 mm
Basal 150 345 mm
AN
Basal 150 345
CU CU-IND
Time, minutes
Fig. 1. The effect of sham hemodialysis on leg amino acid release. The
bars represent net leg release of tyrosine (A), phenylalanine (B) and the
sum of all measured amino acids AA (C) before (basal) and at 150 and
345 mm after the start of the sham hemodialysis procedure in the CU
(filled bars), CU-IND (open bars) and AN groups (striped bars). * and
** denote F <0.02 and P < 0.01, respectively, compared with basal.
was 13.6 2.2%. Third, in the CU group a tendency to
increased arterio-femoral venous differences, that is, release, at
345 minutes as compared with basal values was observed for all
individual amino acids. Calculated for all measured amino acids
the increase was statistically significant (P < 0.005). Fourth, in
group CU-IND leg blood flow was approximately 50% higher at
345 minutes compared to the basal level. However, in this
group there was a tendency to decreased rather than increased
arterio-femoral venous amino acid concentration differences,
resulting in unchanged efflux of amino acids from the leg. The
present results therefore allow the conclusion that in vivo
contact between blood and regenerated cellulose membranes in
a dialyzer leads to increased release of amino acids from
peripheral tissues.
In the CU group the leg release of tyrosine and phenylalanine
increased by approximately 130% (P < 0.02). These amino
acids are neither synthesized nor degraded in muscle tissue
[241. Although both skin and bone marrow actively metabolize
amino acids and protein, amino acid exchange in the leg mainly
represents exchange across muscle. An increased net release of
these amino acids therefore directly reflects either a decreased
rate of protein synthesis or an increased rate of muscle protein
breakdown. An assumption implicit in this conclusion is that
the intracellular free pools of these amino acids are unchanged.
The intracellular free amino acid concentrations were not
measured in this study. However, under the experimental
conditions of sham-hemodialysis plasma amino acid concentra-
tions remained at basal levels throughout the study, and it is
therefore reasonable to assume that the intracellular free amino
acid concentrations were not changed. The increased net re-
lease of tyrosine and phenylalanine following sham-HD there-
fore implies that blood-membrane interaction leads to an in-
crease in protein breakdown or decrease in protein synthesis or
a combination of both.
It is recognized that blood-membrane interaction in a dialyzer
induces several biological effects, such as stimulation of the
complement system, aggregation of granulocytes, transient
leucopenia and release of granulocytic enzymes, clotting and
thrombocyte activation [15]. These signs of bioincompatibiiity
are especially prominent when using dialyzers with regenerated
cellulose membranes. It has been demonstrated that interaction
between blood and such membranes induces release of elastase
and other granulocytic enzymes [25—281. However, since cata-
bolic granulocytic enzymes, such as elastase, are rapidly inac-
tivated in plasma [27], it is doubtful that they can have a
generalized effect on protein turnover. More probably, blood-
membrane interaction may cause the release of other factors
which directly or indirectly induce catabolism of muscle pro-
tein. One such factor is IL-i (so called endogenous pyrogen),
which, together with other monokines, is synthesized and
released by monocytes after stimulation by exogenous pyro-
gens or by complement activation through C5a [29]. According
to the IL-i hypothesis the increased release of IL-i from
monocytes during hemodialysis may be induced by endotoxins
directly [301 or via complement activation or acetate in the
dialysis fluid [161. Furthermore, recent observations have con-
firmed that the concentrations of IL-i are elevated in dialysis
patients before dialysis and that IL-i levels increase further
during dialysis with regenerated cellulose membranes [18, 31].
However, in the present study blood was circulated through a
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dialyzer without concomitant circulation of dialysate, so endo-
toxins or acetate could not have contributed to monocyte
activation.
Utilizing partially purified human IL-I, Baracos et al [191
demonstrated that IL-i induces protein breakdown. However,
in later experiments they were unable to induce a similar effect
with recombinant IL-i [20]. Further studies are required to
identify the specific monokine(s) which stimulate muscle pro-
tein breakdown. Also, it has been appreciated that the assays
showing raised circulating levels of IL- 1 have been unspecific
[32]. Similar assays were used for measuring this monokine in
hemodialysis patients [18, 31]. It is therefore possible that other
monokines may have been measured in addition to IL-i,
Therefore, the alleged role of IL-i with respect to protein
breakdown can not with certainty be separated from that of
other monokines. In this study the peak effect of blood-
membrane contact on leg amino acid balance in group CU was
observed 345 minutes after the start of the 150 minute sham
hemodialysis, an observation of interest when discussing the
potential role of IL-i as a mediator of the protein breakdown
associated with hemodialysis, since in human studies increased
release of IL-i has been observed three to four hours after
activation of monocytes [331. It has been shown in other clinical
studies that the serum urea concentration rises faster in the first
three to four hours after a regular hemodialysis treatment than
in the remaining interdialytic period. However, it remains
controversial whether this phenomenon reflects increased urea
generation or redistribution of the urea [34].
Since it has been demonstrated that monokines induce in-
creased muscle proteolysis through activation of PGE2 [19], our
observation that sham-HD did not increase amino acid release
in the six subjects of group CU-IND to whom indomethacin was
administered supports the suggestion that the catabolic effect of
blood-membrane interaction may be mediated through stimula-
tion of prostaglandins production by some monokine(s). An
effect on leg release of amino acids by indomethacin through
any other mechanism than prostaglandin inhibition is not likely,
since results from in vitro studies indicate that indomethacin
does not influence the release of amino acids from skeletal
muscle in the absence of a catabolic stimulus [35].
Interestingly, sham-hemodialysis using AN membranes did
not result in increased amino acid efflux from leg tissues,
implying that the protein catabolic effect of blood-membrane
contact depends on the biochemical properties of the dialyzer.
Haeffner-Cavaillon et al [30] recently showed a close correla-
tion between intradialytic increases in IL-i production and C3a
levels in a group of dialysis patients using regenerated cellulose
membranes. In another group of patients in whom no comple-
ment activation occurred when dialyzed with AN membranes
IL-i remained at baseline levels. These results may indirectly
support our hypothesis that the catabolism-triggering effect of
contact between blood and CU membranes is mediated by IL- 1
via complement activation.
Unexpectedly, we found that basal arterial concentrations of
several individual amino acids were significantly lower in the
CU-group compared with CU-IND and AN groups. However,
the balance of amino acid across the leg tissues did not differ
between the three groups at the basal state. Therefore it is not
likely that the difference in basal arterial amino acid levels
contributed to the different response in the three groups with
respect to leg amino acid exchange during sham-HD. One may
speculate whether hormonal mechanisms might have contrib-
uted to the increased leg release of amino acids. Theoretically,
a decrease in circulating insulin levels would result in enhanced
efflux of amino acids from muscle. Plasma insulin levels were
not measured. However, under the conditions of sham-hemo-
dialysis loss of insulin by dialysis can be excluded. Although
some insulin may have adhered to the dialysis membranes early
during the sham-hemodialysis procedure, this should in healthy
subjects have resulted in an increased release of insulin from
the f3-cells. It is therefore not likely that hypoinsulinemia
contributed to the enhanced leg amino acid release, which
reached its maximum more than five hours after the start of the
sham-hemodialysis. One may also speculate that the stress
related to the extracorporeal circulation per se or prolonged
fasting may have contributed to the increase amino acid release
in the CU-group. However sham-hemodialysis using AN69
membrane did not result in increased amino acid release. Since
identical protocol were followed in the two series of sham
hemodialysis using regenerated cellulose and AN 69 membrane,
respectively, it seems highly unlikely that other factor than
blood-membrane interaction, such as time, recumbent position,
the stress of extracorporeal circulation or heparin administra-
tion, appreciably contributed to the observed increase in leg
amino acid release in association with sham-hemodialysis using
regenerated cellulose membrane.
As commented above, leg blood flow increased markedly in
both the CU and the CU-IND groups, although the increase
tended to be larger in the former group. In contrast leg blood
flow did not change during or following sham-hemodialysis
using AN membranes. The mechanism(s) causing the increase
in blood flow in the two regenerated cellulose groups is not
evident. However, IL-i has been shown to play a role in
modulating vascular reactivity under various conditions. Thus,
IL-I inhibits vascular smooth muscle contractility in vitro [36].
Also infusion of IL-i into rabbits have been shown to induce
vasodilatation [37]. Furthermore, in healthy subjects marked
increases in arm blood flow have been observed after stimula-
tion of endogenous IL-i activity by the administration of
etiocholanolone [38]. One may therefore speculate whether
IL- 1 or some other factor, triggered by blood-membrane inter-
action, could have mediated the increase in blood flow, In the
CU-IND group the increase in leg blood flow may have been
attenuated by indomethacin.
Although the effect of blood-cuprophane interaction on pro-
tein metabolism was not directly determined by kinetic mea-
surements of tracer substances, our results allow some quanti-
tative estimation with respect to whole body protein balance. In
the present study amino acids were measured in plasma.
However, blood cellular elements, presumably erythrocytes,
contribute to the net flux of amino acids from muscle. Study of
amino acid exchange across the leg in humans has shown that
the directions of net amino acid transport in blood cells and
plasma are parallel, and that for most free amino acids the
arterial-femoral venous differences in whole blood are at least
as large as those in plasma [39]. Hence, there should be little
risk that leg amino acid efflux will be overestimated if, in the
following quantitative assessment, the arterial-femoral venous
differences for whole blood amino acids are assumed to equal
those observed for plasma amino acids. If it is further assumed
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that the release of amino acids from leg muscle reflects that of
the total body muscle mass, estimated to be 40% of the body
weight, the efflux of tyrosine and phenylalanine from the total
muscle mass at 345 minutes exceeded that in the basal state by
2400 and 2600 nmollmin, respectively. From the present data it
can be assumed that amino acid release increased after 2.5
hours from the start of sham-HD and continued to increase for
a further three and a half hours. It then returned towards basal
level during the following three to four hours. The total amount
of tyrosine and phenylalanine released from muscle in response
to the sham-hemodialysis procedure can then be calculated to at
least 500 and 550 smol, respectively. By knowing the amino
acid composition of skeletal muscle [40], these amounts can be
calculated to correspond to a loss of 13 to 16 g of muscle
protein. Although the changes in amino acid metabolism during
a single sham-hemodialysis in healthy subjects do not necessar-
ily reflect those occurring in uremic patients undergoing main-
tenance hemodialysis, it is not inconceivable that the stimula-
tion of protein catabolism could be even higher during clinical
dialysis than in our experiments, since most hemodialysis
treatments are performed using higher blood flow, longer dura-
tion, and sometimes larger surface area as compared with the
present experimental study (blood flow 100 mI/min/m2 during
150 mm). Rotellar et al [41] recently reported that dialysis for
six hours using two parallel 2.5 m2 hollow-fiber cellulose acetate
dialyzers (blood flow 500 mi/mm) resulted in a larger loss of
urea into the dialysate than could be accounted for by urea
clearance from body fluids. This discrepancy may be due to
enhanced urea formation during dialysis corresponding to an
additional protein breakdown of about 60 g. An increase of this
magnitude would be in keeping with our results in normal
subjects, considering that the surface area was larger, the blood
flow higher, and the duration of the dialysis considerably longer
in Rotellar's study. Increased catabolism at each dialysis treat-
ment of 15 g of protein, that is, an amount approximately equal
to the calculated increase in protein degradation in the present
study may, in addition to the 10 to 15 g of free and peptide-
bound amino acids lost by dialysis, be critical in many mainte-
nance hemodialysis patients who tend to have a low protein
intake. If patients can not meet the increased protein require-
ment by eating a protein-rich diet, malnutrition will develop,
leading to increased morbidity and impaired quality of life.
In dialysis patients with suboptimal nutritional status it is of
obvious importance to minimize catabolic stimuli associated
with the dialytic procedure. In view of the present results,
suggesting that polyacrylonitrile membranes do not induce
increase in muscle protein breakdown, hemodialysis using
membranes with less complement activating properties may
seem attractive. However, one should be cautious in directly
extrapolating data obtained under the experimental conditions
of sham hemodialysis to hemodialysis treatment. In clinical
dialysis non-complement dependent factors, such as acetate in
the dialysate or contamination of the dialysis fluid by endotox-
ins, may lead to an increase in IL-l production. The impact of
such factors might be enhanced when dialysis is performed
using high permeability membranes.
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